speb/financial-data huggingface dataset:
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 5507800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 28407100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 34616800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 56800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 12105500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 12162300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 650000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 24322600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 200900000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Depreciation: 3240800000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 3240800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 3240800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 3240800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 539600487.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 14.64
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 7901100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — EBIT: 12318300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — EBITDA: 15559100000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -8800000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 456700000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 34100000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -266400000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 4998000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 37400000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 2100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 638200000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 2592300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 15818000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 50575800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Gross Profit: 31735100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 9800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Interest Expense: 1228900000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1228900000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Interest Income: 45600000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 45600000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1404000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 45600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Inventory: 16848100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 60095000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -9960600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 35100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 464900000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 74400000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 4684500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2241600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 374400000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 7614200000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 7988600000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 3835000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -2468300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 464900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 814700000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 29734800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 111300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Minority Interests: -33200000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -223000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 74400000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Net Debt: 19263000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 124200000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income: 7901100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 7901100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 7934300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 7901100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 7901100000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 11089400000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 7934300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -1380300000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 91700000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2216200000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1366700000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1380300000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 91700000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 37001700000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -9874900000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 849500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 37783000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1255000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 824500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 814700000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1509800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 15557200000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Normalized Income: 7899725920.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 9939000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Operating Income: 12942700000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 60142200000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 538650925.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 23100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 630000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 120800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 129300000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 1409100000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1195700000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1255000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 10400000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 7930000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2088000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1334300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 542000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 27900000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Other Special Charges: 2100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Payables: 9197300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 200900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 904800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Pretax Income: 11089400000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 6100000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -223000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -9901600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 6229300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 28407100000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 3240800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 23000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 23000000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -2468300000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Research And Development: 255900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 27900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 33020100000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 26700000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1161400000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1799600000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 538650925.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 849500000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Special Income Charges: 1900000.00
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 74800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 40375300000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 37783000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 525920.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Tax Provision: 3123000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.28
LAURUSLABS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2854900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 76604000000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 47989500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 20150900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 40486600000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Total Expenses: 47199500000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 36117400000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 41987200000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 11794800000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 197000000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 1900000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 1900000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Work In Process: 5620800000.00
LAURUSLABS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 10294200000.00
LAURUSLABS.NS income_statement (annual, 2023-03-31) — Write Off: -4000000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 21078400000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 50018000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 10512400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 16629200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -17168200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 7170800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -56100000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Amortization: 49100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 100000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 538749879.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Basic EPS: 2.98
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 456700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 13665400000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -6783100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 703500000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1077900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1389400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1389400000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -861800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 171300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1218100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -1513100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -385000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -885200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Payable: 3344100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -851000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -290200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 931000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1077900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 41109500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 25600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4228400000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 24990900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 38349700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 81900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 17088200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 17170100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 362100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 31122800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 248100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Depreciation: 3845800000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3845800000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 3845700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 3796600000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 539665671.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 2.97
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1605500000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — EBIT: 4081200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — EBITDA: 7927000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 1700000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1389400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 34100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2498300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 4958000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -126200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 19300000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 666300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2653200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 16685300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 57643500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Gross Profit: 25027100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 2200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Interest Expense: 1717600000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1717600000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Interest Income: 56100000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 56100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1743100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 56100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Inventory: 18454100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 66180000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -8224200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 34200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 1205700000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 25600000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 7577400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 2277700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 621600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 7982300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 8603900000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3638600000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -2166900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 1205700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 934700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 35688800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 46200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Minority Interests: -17200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -1516200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 25600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Net Debt: 23681100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -88200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income: 1605500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1605500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1622700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1605500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1605500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2363600000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1622700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -1740500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -4000000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 5410500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 1471700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1740500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -4000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 40475300000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -6760100000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 3938800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 38456300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 1059500000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 570400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 934700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 984000000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 7775800000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Normalized Income: 1497895701.47
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 6656900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Operating Income: 3948700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 50018000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 538965858.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 9600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 488400000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 214700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 190200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1693900000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 648800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1059500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 100000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 8752300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1520300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 1783200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 322800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 115300000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Other Special Charges: -151200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Payables: 12035600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 248100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1515300000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Pretax Income: 2363600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 49200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -1516200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -6783100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 6701400000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 24990900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3845800000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 22600000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 22600000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -2166900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Research And Development: 437600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 27100000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 33149500000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 23000000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1344900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2011200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 538965858.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 3938800000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Special Income Charges: 151200000.00
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 109200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 41109500000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 38456300000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 43595701.47
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Tax Provision: 681500000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.29
LAURUSLABS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1045700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 83870300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 49091800000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 25774000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 41155700000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Total Expenses: 46069300000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 42714600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 45520600000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 11591800000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 79000000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 362100000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 151200000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 151200000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Work In Process: 6794700000.00
LAURUSLABS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 7226900000.00
LAURUSLABS.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — +Operating Expense: 6045800000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — +Total Revenue: 12237000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 10582300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 17499600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1758400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 536216216.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.37
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 672600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 1078300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 432200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 518700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 1078300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 41339400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 5213400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 5483000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 41197100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 84100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 20603500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 20687600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 34594600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 271500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 1075100000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 1075100000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 536216216.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.37
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — EBIT: 754200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — EBITDA: 1829300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 2463000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2633000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 40940200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Gross Profit: 6754000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Interest Expense: 526100000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 526100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 21071300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 68557100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1758400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 588500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 6614200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 7202700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 976800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 102200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Minority Interests: -1100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 26785500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: 199500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: 199500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Interest Income: -526100000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -526100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 40940200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 38706400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 293200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Normalized EBITDA: 1829300000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Normalized Income: 198400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Operating Income: 708200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Operating Revenue: 12237000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 539159314.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 2099500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1118700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 40261100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 170000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 723100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 2360600000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 46000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 3183500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 35726800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 8000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 86500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 10957700000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Pretax Income: 228100000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 5483000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 1075100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 539159314.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 41339400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 38706400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Tax Provision: 50900000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.22
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 87292800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 47953600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 27890300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 41441600000.00
LAURUSLABS.NS income_statement (quarterly, 2024-09-30) — Total Expenses: 11528800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 45851200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 46095700000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 11256600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 375400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 6602500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 6258400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 14150500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 539766082.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.71
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 6101500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 1060900000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 1060900000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 539766082.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.71
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — EBIT: 1884800000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — EBITDA: 2945700000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 8049000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 578000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 578000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -6400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 929400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 929400000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -578000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -578000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 2945700000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 923000000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Operating Income: 1790600000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 14150500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 94200000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 3306300000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1306800000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 6101500000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 1060900000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 400700000.00
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.31
LAURUSLABS.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 12359900000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 23432700000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 6274500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 55078600000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 17203000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 9584900000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 9584900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 20071600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 20071600000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -20956400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -20956400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 7328400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7328400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -508500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -508500000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Amortization: 58500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 100000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 539152333.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 538410138.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Basic EPS: 6.65
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.34
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1389400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 15624000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 15624000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -6410000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 706500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 706500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1078500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1078500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 995400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 995400000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 995400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 995400000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -431300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 84300000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 84300000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 911100000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 911100000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -828600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -549600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 2661700000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Payable: -979900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -4049600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -3746000000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -407900000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1078500000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1078500000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 44725600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 44725600000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 101700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 4583600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 4583600000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 25394100000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7826800000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 43323200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 43323200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 84600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 84600000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 20475000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 20475000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 20559600000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 20559600000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 572000000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 572000000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 35397200000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 35397200000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 293400000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 293400000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Depreciation: 4300900000.00
LAURUSLABS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 4300900000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 4301000000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1104300000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 4242500000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1104300000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 539593520.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 539653580.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 6.64
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.33
LAURUSLABS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 3583200000.00
LAURUSLABS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2336700000.00
LAURUSLABS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 2800000.00
LAURUSLABS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 2800000.00
LAURUSLABS.NS income_statement (annual, 2025-03-31) — EBIT: 6908800000.00